The Centers for Disease Control (CDC) is seeking applications for the Comprehensive Provision of Integrated, High-Quality Community- and Facility-Based HIV and Tuberculosis (TB) Services in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR).
The overall objective of the NOFO is to support the acceleration and maintenance of sustainable, high-quality, comprehensive HIV and TB services to achieve and sustain the 95-95-95 targets and epidemic control in Namibia. It will support the implementation of programs in selected geographic areas in facility and/or community settings.
The comprehensive package of services will include targeted HIV case-finding with immediate linkage to appropriate services; adult and pediatric prevention and treatment; TB prevention, diagnosis, and treatment; elimination of mother-to-child transmission (EMTCT); cervical cancer prevention, screening, and treatment; surveillance of HIV, TB, and related health conditions; improved quality, access, and use of health information systems; and strategic information (SI). The NOFO will fund one or more recipient(s) that will provide technical assistance and capacity building to the Ministry of Health and Social Services (MHSS) at the facility and/or community levels in one or more assigned geographic areas of Namibia. Expected outcomes will include a sustainable, integrated, and efficient health system; increased responsiveness to remaining and emerging gaps in HIV and TB prevention, care, and treatment; reduced HIV- and TB-related morbidity and mortality; reduced HIV and TB incidence; supporting efforts toward the EMTCT of HIV; and overall improved health outcomes.
Goals and Priorities
- Reducing the prevention and treatment gaps for adolescent girls and young women (AGYW), children, and key populations (KP);
- Strengthening national and local programmatic, financial, and community leadership;
- Designing new partnerships with key private, public, and multi sector entities that can complement existing programs and expand reach;
- Utilizing the PEPFAR platform for broader disease surveillance and public health programming, consistent with the PEPFAR legislative and funding authority;
- Investing in the scale-up of cutting edge behavioral, and implementation science to bend the curve on new infections;
- Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs), and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART);
- Strengthening the capacity of countries to collect, use, and share surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring, and HIV screening for blood safety; and
- Developing, validating, and/or evaluating public health programs to inform, improve, and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB, and opportunistic infections.
- The expected number of awards is 1-4.
- Average One Year Award Amount: $34,500,000
- State governments or their bona fide agents (includes the District of Columbia) Local governments or their bona fide agents
- Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau
- State controlled institutions of higher education
- American Indian or Alaska Native tribal governments (federally recognized or state-recognized)
- Non-government Organizations
- American Indian or Alaska native tribally designated organizations
- Ministries of Health
For more information, visit Grants.gov.